These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27358106)

  • 21. Mixed backbone antisense glucosylceramide synthase oligonucleotide (MBO-asGCS) loaded solid lipid nanoparticles: in vitro characterization and reversal of multidrug resistance in NCI/ADR-RES cells.
    Siddiqui A; Patwardhan GA; Liu YY; Nazzal S
    Int J Pharm; 2010 Nov; 400(1-2):251-9. PubMed ID: 20816930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of levosulpiride-loaded solid lipid nanoparticles and their
    Khaleeq N; Din FU; Khan AS; Rabia S; Dar J; Khan GM
    J Microencapsul; 2020 Mar; 37(2):160-169. PubMed ID: 31916886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doxorubicin-loaded micelles of reverse poly(butylene oxide)-poly(ethylene oxide)-poly(butylene oxide) block copolymers as efficient "active" chemotherapeutic agents.
    Cambón A; Rey-Rico A; Mistry D; Brea J; Loza MI; Attwood D; Barbosa S; Alvarez-Lorenzo C; Concheiro A; Taboada P; Mosquera V
    Int J Pharm; 2013 Mar; 445(1-2):47-57. PubMed ID: 23380628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH; Wu CT; Fang JY
    Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation.
    Eskandani M; Nazemiyeh H
    Eur J Pharm Sci; 2014 Aug; 59():49-57. PubMed ID: 24768857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pH-responsive asymmetric lipid vesicle as drug carrier.
    Zhang X; Zong W; Hu Y; Luo N; Cheng W; Han X
    J Microencapsul; 2016 Nov; 33(7):663-668. PubMed ID: 27682414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotype.
    Safrit JT; Berek JS; Bonavida B
    Gynecol Oncol; 1993 Feb; 48(2):214-20. PubMed ID: 8428693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and evaluation of metformin-loaded solid lipid nanoparticles for celluar and mitochondrial uptake.
    Xu Q; Zhu T; Yi C; Shen Q
    Drug Dev Ind Pharm; 2016; 42(5):701-6. PubMed ID: 26288997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation, characterization and cytotoxicity studies of alendronate sodium-loaded solid lipid nanoparticles.
    Ezzati Nazhad Dolatabadi J; Hamishehkar H; Eskandani M; Valizadeh H
    Colloids Surf B Biointerfaces; 2014 May; 117():21-8. PubMed ID: 24607519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New doxorubicin nanocarriers based on cyclodextrins.
    Viale M; Giglio V; Monticone M; Maric I; Lentini G; Rocco M; Vecchio G
    Invest New Drugs; 2017 Oct; 35(5):539-544. PubMed ID: 28378257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. pH-responsive delivery of doxorubicin from citrate-apatite nanocrystals with tailored carbonate content.
    Rodríguez-Ruiz I; Delgado-López JM; Durán-Olivencia MA; Iafisco M; Tampieri A; Colangelo D; Prat M; Gómez-Morales J
    Langmuir; 2013 Jul; 29(26):8213-21. PubMed ID: 23735159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.
    Pandey V; Gajbhiye KR; Soni V
    Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation, characterization, and anti-tumor property of podophyllotoxin-loaded solid lipid nanoparticles.
    Zhu RR; Qin LL; Wang M; Wu SM; Wang SL; Zhang R; Liu ZX; Sun XY; Yao SD
    Nanotechnology; 2009 Feb; 20(5):055702. PubMed ID: 19417361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solvent injection-lyophilization of tert-butyl alcohol/water cosolvent systems for the preparation of drug-loaded solid lipid nanoparticles.
    Wang T; Wang N; Zhang Y; Shen W; Gao X; Li T
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):254-61. PubMed ID: 20447810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of hypericin-loaded solid lipid nanoparticles: physicochemical properties, photostability and phototoxicity.
    Youssef T; Fadel M; Fahmy R; Kassab K
    Pharm Dev Technol; 2012; 17(2):177-86. PubMed ID: 21047275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin.
    Zhang J; Chen XG; Sun GZ; Huang L; Cheng XJ
    Colloids Surf B Biointerfaces; 2010 Jun; 77(2):125-30. PubMed ID: 20172698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin.
    Jain A; Kesharwani P; Garg NK; Jain A; Jain SA; Jain AK; Nirbhavane P; Ghanghoria R; Tyagi RK; Katare OP
    Colloids Surf B Biointerfaces; 2015 Oct; 134():47-58. PubMed ID: 26142628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipophilic Prodrug of Floxuridine Loaded into Solid Lipid Nanoparticles:
    Chirio D; Peira E; Battaglia L; Ferrara B; Barge A; Sapino S; Giordano S; Dianzani C; Gallarate M
    J Nanosci Nanotechnol; 2018 Jan; 18(1):556-563. PubMed ID: 29768881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.